| Angela Joy Conant-suane, MS CCC-SLP | |
|
351 Marion Dr, Baton Rouge, LA 70806-4412 | |
| (225) 276-5589 | |
| Not Available |
| Full Name | Angela Joy Conant-suane |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 351 Marion Dr, Baton Rouge, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174241707 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Angela Joy Conant-suane, MS CCC-SLP 351 Marion Dr, Baton Rouge, LA 70806-4412 Ph: (225) 276-5589 | Angela Joy Conant-suane, MS CCC-SLP 351 Marion Dr, Baton Rouge, LA 70806-4412 Ph: (225) 276-5589 |
News Archive
Healthy eating habits are more important than ever, with advocates calling for fast-food restaurants, schools and food providers to promote the sale of salads and vegetables as alternatives to burgers and fries. According to new Cornell University research, the most effective strategy for influencing such healthy food choices is not calorie counts and reduced prices, but rather more subtle incentives that reward healthy eating behavior.
Researchers with the National Cancer Institute (NCI) have found that the prevalence of tamoxifen use for the prevention of breast cancer among women without a personal history of breast cancer is very low.
Janssen-Cilag International NV, today announced it has submitted a Marketing Authorisation Application to the European Medicines Agency seeking approval for a once-daily single tablet fixed-dose antiretroviral combination product containing darunavir, a protease inhibitor developed by Janssen, with cobicistat, a pharmacokinetic enhancer or boosting agent, developed by Gilead Sciences, Inc. for use in combination with other human immunodeficiency virus medicines.
Celsion Corporation announced today that after reviewing data from 294 patients including data from 12 Japanese patients enrolled in the pivotal Phase III ThermoDox® clinical study (HEAT Study) for primary liver cancer, the Data Monitoring Committee (DMC) has recommended that Celsion continue to enroll patients in the trial.
The most common genetic cause of Parkinson's is not only responsible for the condition's distinctive movement problems but may also affect vision, according to new research by scientists at the University of York.
› Verified 5 days ago
Miss Elizabeth Guillory Bailey, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12264 Queensbury Ave, Baton Rouge, LA 70815 Phone: 337-412-1344 | |
Deborah Lynne Griffin, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6021 Cottage Row Dr, Baton Rouge, LA 70817 Phone: 225-754-7663 | |
Elizabeth Tran, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 714 Jennifer Jean Dr, Baton Rouge, LA 70808 Phone: 504-914-9532 | |
Ms. Kimberly Dominick, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5536 Superior Dr Ste C, Baton Rouge, LA 70816 Phone: 225-229-4511 | |
Rebecca Woodall, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5601 Upton Dr, Baton Rouge, LA 70809 Phone: 225-293-3210 | |
Mrs. Erin Bonfanti Chesser, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6550 Sevenoaks Ave, Baton Rouge, LA 70806 Phone: 225-929-8602 | |
Barbara Germany, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 18268 Petroleum Dr, Baton Rouge, LA 70809 Phone: 225-292-4138 |